查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855378

伴侣动物诊断市场按诊断测试类型、产品类型、动物类型、最终用户和应用划分－2025-2032年全球预测

Companion Animal Diagnostics Market by Type Of Diagnostic Test, Product Type, Animal Type, End-User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，伴侣动物诊断市场规模将达到 65.5 亿美元，复合年增长率为 8.88%。

关键市场统计数据
基准年 2024 33.1亿美元
预计年份：2025年 35.9亿美元
预测年份 2032 65.5亿美元
复合年增长率 (%) 8.88%

一篇关于不断发展的伴侣动物诊断环境的简明说明重点介绍了再形成医疗保健的技术、临床和监管驱动因素。

由于技术创新、临床实践的转变以及饲主对更精准、更及时的兽医服务的日益增长的期望，伴侣动物诊断领域正以前所未有的速度发生变化。检测设计、影像技术和分子技术的进步使得疾病的早期发现、更个人化的治疗方案以及治疗效果的监测成为可能。随着兽医诊所采用更先进的内部检测能力，即时筛检和实验室级诊断之间的界线日益模糊，重塑诊所和专科中心的工作流程模式和服务内容。

法律规范和专业指南同步发展，影响诊断工具和服务的验证标准、品管预期以及资料管治实务。这种动态的监管环境促使製造商和服务供应商加强证据生成、声明佐证和上市后监测活动。同时，从寻求快速临床决策支援的临床医生到寻求透明度和连续性护理的饲主，相关人员的期望正在推动互操作系统、标准化报告格式和更清晰的疗效指标的出现。

综合来看，这些因素正在重新定义竞争优势。那些能够将强大的分析性能与临床工作流程的无缝整合、卓越的客户支援以及经临床验证的效用相结合的公司，更有可能获得最持久的市场地位。本导言将重点放在这些变革性变化及其对诊断生态系中各参与者的影响。

对将彻底改变兽医实践中诊断技术、临床工作流程和商业模式的重大变革进行清晰的描述

伴侣动物诊断产业的格局正受到多项变革性因素的重塑，这些因素共同作用，重新定义了该产业的整体价值提案。首先，分子诊断和次世代定序的成熟，拓展了诊断套件的范围，使其超越了传统的形态学和血清学检测，从而能够进行精准的病原体鑑定、遗传风险分析和靶向肿瘤检测。同时，即时检测技术和小型化分析仪的出现，使得检测分散化，许多诊所能够在现场进行血液学、化学和快速传染病检查，从而缩短诊断时间，并有助于即时进行临床干预。

资讯学和数据整合也日益凸显。云端基础平台、实验室资讯系统和诊断中间件正在改善样本追踪、结果解读和病患监测。这个数位化层面支援决策支援演算法，并促进远距会诊、远端医疗追踪以及新发病原体的群体监测。此外，标准化品管和认证计画的日益普及也提高了医疗服务提供者对分析可靠性的基本期望。

试剂和耗材的订阅式服务协议、捆绑式诊断包以及伴随诊断的价值基本契约正逐渐成为供应商的战略选择。将临床证据产生、工作流程整合和敏捷服务模式融入产品中的公司将更有利于吸引临床医生并建立长期的业务关係。

对2025年关税调整将如何影响供应链韧性、区域筹资策略和临床医生采购行为进行实际分析

计划于2025年实施的关税调整和贸易政策变化，为伴侣动物诊断供应链中的製造商、经销商商和终端用户带来了新的营运挑战。某些市场对医疗设备和试剂征收更高的进口关税，挤压了依赖全球采购的供应商的利润空间，促使他们重新评估分销策略、定价模式和供应商关係。拥有地理位置分散的生产基地和灵活的製造外包协议的製造商可以缓解近期成本压力，并稳定向兽医诊所和实验室的供应。

除了直接的成本影响外，关税还在推动供应链的策略转型。一些供应商正在加速零件生产和最终组装的在地化进程，以降低跨境关税和运输中断带来的风险。这种在地化趋势正在影响前置作业时间、库存策略以及扩张和合作的资本投资决策。对于最终用户而言，采购团队正在重新审视总体拥有成本的计算方法，将关税引起的价格波动、运费以及关税相关的延误纳入考量。

同时，关税驱动的市场动态正在影响临床应用模式。当进口诊断平台的价格竞争力下降时，本地替代方案和模组化内部检测开发可能会更受欢迎，尤其是在那些有能力检验新检测方法的大型兽医诊所和研究中心。製造商与经销商之间进行策略合作，提供捆绑服务、延长保固期和培训，可以抵消预期成本上涨的影响，并在关税相关的不确定性中维持临床服务的连续性。

详细的细分洞察揭示了诊断测试类型、产品类别、动物群体、最终用户环境和临床应用如何影响策略重点。

透过精细的细分视角，我们可以清楚地了解临床需求、技术契合度和机会在多个诊断类别中的交集。诊断测试类型包括血液学测试（例如凝血试验和全血细胞计数）、组织病理学程序（包括切片检查和细胞学工作流程）、影像学（包括超音波和X光）、分子平台（包括DNA序列测定和基于PCR的检测）以及血清学方法（包括凝集试验和ELISA检测）。每种测试类型都有不同的分析要求、检体处理通讯协定和训练需求，这些都会影响兽医诊所和参考实验室的采购决策。

产品类型分为耗材和仪器/分析仪，其中耗材定义为试剂和检测套组，仪器定义为临床化学分析仪、血液分析仪、免疫诊断分析仪、分子诊断仪器等类别。这种划分突显了试剂的经常性成本与分析仪的资本支出在采购节奏上的差异，进而影响供应商的收入模式与销售策略。

动物物种涵盖鸟类、猫、狗、豚鼠和马，这种多样性要求检测方法的验证必须考虑物种特异性参考区间、样本基质以及临床解读框架。最终使用者细分包括内部实验室、研究实验室和兽医医院/诊所，其中内部实验室又可进一步细分为动物收容所和宠物饲主，反映了不同的资源规模和技术能力。应用细分包括内分泌检测、基因检测、感染疾病诊断、营养分析、肿瘤学、治疗药物监测和毒理学检测等领域。认识到这些相互交织的细分维度，有助于相关人员优先制定针对不同最终用户群体的产品蓝图、检验测试和商业性策略。

策略性区域洞察，阐释美洲、欧洲、中东和非洲以及亚太市场在采用率、监管和商业模式方面的差异

区域动态对技术采纳、监管路径和商业实施策略有显着影响。在美洲，高度集中的专业兽医诊所和先进的参考实验室，以及完善的分销网络和成熟的私人诊所生态系统，正推动着高通量分子诊断和整合诊所管理工作流程的快速普及。相较之下，欧洲、中东和非洲地区（EMEA）的情况则较为复杂，监管协调工作与市场分散并存。在西欧，成熟的兽医诊所推动了对经过验证和认证的解决方案的需求，而新兴市场则优先考虑能够应对该地区疾病负担的、经济高效且适应性强的诊断方案。

在亚太地区，快速的都市化、宠物饲养量的增长以及兽医教育基础设施的不断完善，正推动着对就地检验和先进化验服务的需求。在地化生产和区域合作在亚太地区日益重要，有助于加速市场进入并应对价格敏感度问题。在所有地区，报销模式、诊所整合趋势以及专科培训计画的差异，都在影响诊断技术普及的速度和模式。为了实现持续普及，供应商必须根据这些区域差异调整其打入市场策略，在标准化的全球产品平台与特定区域的监管措施、分销框架和服务模式之间取得平衡。

提供切实可行的公司层面洞察，重点在于竞争差异化策略、伙伴关係途径和创新重点，以实现永续的市场渗透。

随着现有企业、专业设备製造商、试剂供应商和创新分子诊断公司寻求差异化的价值提案，伴侣动物诊断领域的竞争格局正在不断演变。成功越来越依赖整合式解决方案，即可靠的仪器、高效的耗材、简化的工作流程和强大的售后服务。那些投资于临床证据产生、第三方检验和跨物种参考数据的公司，正在赢得兽医临床医生和实验室主任的信任，从而帮助他们维持长期的采购合作关係。

联盟和策略伙伴关係正逐渐成为加速市场渗透的有效途径。将诊断专长与数位健康平台、远端医疗提供者或诊所管理系统结合的联盟，能够打造极具吸引力的捆绑式解决方案，有效解决临床医生工作流程中的痛点，并改善患者预后追踪。此外，投资于培训、远距离诊断支援和技术服务网路的机构，能够降低使用者接受新方案的门槛，并提高客户维繫。

试剂化学、微射流和可携式设备的创新正在开闢新的竞争领域，速度、易用性和检测的稳定性决定临床医生的偏好。那些围绕终端使用者实际需求（例如有限的实验台空间、可变的样本量以及对快速、可操作结果的需求）开发产品的公司，更有可能在市场上取得成功。最后，透明的上市后监测和对监管变化的快速反应将有助于增强信任，并降低新技术应用的门槛。

为行业领导者提供切实可行的、优先排序的建议，以协调产品、证据、定价和分销策略，从而推动临床应用和成长。

透过将产品、证据和市场策略与不断变化的临床需求相匹配，行业领导者可以果断行动，将市场动态转化为竞争优势。首先，他们优先考虑模组化产品架构，使产品功能能够从基础血液学和化学检测扩展到更高级的分子和血清学检测，而无需昂贵的资本投入。这种方法降低了产品推广的门槛，并透过升级路径支持长期的客户关係。同时，他们投资于可靠的临床检验研究和跨物种参考数据，以证明产品在最常见的伴侣动物群体中的分析性能和临床效用。

在商业性，我们采用灵活的合约模式，结合资本设备租赁、试剂订阅计划和配套服务，以满足从小型诊所到大型转诊中心等不同终端用户的财务能力。当关税影响或物流限制可能削弱竞争力时，我们透过发展本地製造和组装伙伴关係关係来加强区域分销。为了最大限度地减少实施摩擦并增强临床医生的信心，我们还提供有针对性的培训计划、远端技术支援和品质保证资源，以完善产品供应。

最后，它们整合了数位化功能，从而增强了结果解读、数据共用和患者长期追踪。它们可以连接到诊所管理系统，并提供可互通的报告格式，从而支援远端医疗工作流程。随着伴侣动物诊断领域的不断成熟，专注于模组化、证据生成、客户支援和数位化整合将使行业领导者能够获得长期价值。

透明的调查方法，阐明了支撑策略洞见的资讯来源、专家参与、分析框架和限制。

本分析的研究结合了对同行评审的兽医临床文献、监管指导文件和产品技术规范的结构化审查，以及对实验室主任、兽医临床医生、经销商和产品经理的访谈。资料综合强调跨多个资讯来源进行三角验证，以检验技术能力、工作流程影响和区域应用模式。定性专家意见有助于解读临床效用和操作可行性，而二手资讯则提供了监管发展和供应链动态的背景资讯。

分析方法包括诊断平台的功能比较映射、跨物种检测验证方法的评估以及情境分析，以评估关税主导的供应链应对措施。研究强调了调查结果的可重复性和假设的透明度，并且在预测反映了专家对采用可能性或营运影响的意见时，这些判断得到了多位从业人员访谈的支持。这项研究应被视为策略指南，并需辅以持续的市场监测和本地营运环境中的检验。

调查方法确保所提出的见解是基于实践者的实际情况、检验的技术特性和实际的商业性考虑，使决策者能够将研究结果应用于他们的产品开发、采购和临床整合策略。

简明扼要的结论，整合了伴侣动物诊断策略定位的技术、监管和商业性必要性。

总之，伴侣动物诊断正处于一个战略曲折点，技术进步、照护模式转变、法规演变和经济压力交织在一起，重塑价值创造的格局。分子创新、照护现场能力的提升以及数位化工作流程的整合，在提高诊断准确性的同时，也正在改变传统的实验室服务关係。同时，政策措施和关税调整迫使供应商和经销商重新评估筹资策略，并增强本地供应链的韧性。

对于整个生态系统的相关人员而言，未来的发展路径包括：将产品创新与临床效用检验相结合；建构反映终端用户经济实际情况的商业模式；以及投资于能够减少推广阻力的服务框架。本地差异至关重要。针对当地法规环境、分销基础设施和临床实践模式的精准市场策略，优于一刀切的通用策略。最终，那些能够平衡技术卓越性与务实商业化（并以循证医学、培训和快速响应的支持为支撑）的机构，将引领下一阶段的推广应用，并创造可衡量的临床和商业价值。

该结论综合了关键见解，并强调了在快速发展的诊断环境中，制定积极主动的策略以抓住机会和降低营运风险的必要性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 宠物饲养量的增加和宠物拟人化趋势推动了对诊断的需求。
  • 将照护现场免疫检测设备整合到兽医诊所进行快速诊断
  • 兽医诊所越来越多地使用分子PCR检测进行疾病早期诊断。
  • 远端医疗诊断平台在远距伴侣动物照护方面的进展
  • 人工智慧主导的影像分析技术的出现提高了小动物诊断的准确性
  • 人们对照护现场超音波进行伴侣动物全面评估的兴趣日益浓厚
  • 扩展多重生物标记检测组合，用于宠物慢性疾病的早期检测
  • 扩大兽医基础设施以支持广泛的诊断
  • 政府的积极措施和宠物保险的普及正在推动市场扩张。
  • 动物用药品研发与策略合作推动创新

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 伴侣动物诊断市场（依诊断检验类型划分）

  • 血液学
    • 血液凝固检查
    • 全血细胞计数（CBC）
  • 组织病理学
    • 切片检查
    • 细胞学
  • 影像诊断
    • 超音波
    • X射线
  • 分子诊断
    • DNA定序
    • PCR方法
  • 血清学
    • 团聚检测法
    • 酵素连结免疫吸附试验

9. 伴侣动物诊断市场（依产品类型划分）

  • 消耗品
    • 试剂
    • 检测套组
  • 仪器/分析仪
    • 临床化学分析仪
    • 血液分析仪
    • 免疫诊断分析仪
    • 分子诊断分析仪

第十章 按动物类型分類的伴侣动物诊断市场

  • 鸟类
  • 猫
  • 狗
  • 天竺鼠
  • 马

第十一章 伴侣动物诊断市场（依最终用户划分）

  • 内部测试设施
    • 动物收容所
    • 宠物饲主
  • 研究所
  • 兽医医院和诊所

第十二章 伴侣动物诊断市场（依应用领域划分）

  • 内分泌检测
  • 基因检测
  • 感染疾病诊断
  • 营养分析
  • 肿瘤学
  • 治疗药物监测
  • 毒理学检测

13. 伴侣动物诊断市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 伴侣动物诊断市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国伴侣动物诊断市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Agrolabo SpA
    • Biogal Galed Labs
    • BioMerieux SA
    • BioNote, Inc.
    • Demeditec Diagnostics GmbH
    • Eurofins Technologies
    • Fassisi GmbH
    • FUJIFILM Holdings Corporation
    • IDEXX Laboratories, Inc.
    • IDvet
    • Mars, Incorporated
    • Neogen Corporation
    • Nisseiken Co., Ltd
    • Qiagen NV
    • Randox Laboratories, Ltd.
    • Shenzhen Bioeasy Biotechnology Co., Ltd.
    • Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • SKYER, Inc.
    • Skyla Corporation
    • Vimian Group AB
    • Virbac SA
    • Zoetis Inc.
Product Code: MRR-AD517FAA89C5

The Companion Animal Diagnostics Market is projected to grow by USD 6.55 billion at a CAGR of 8.88% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.31 billion
Estimated Year [2025] USD 3.59 billion
Forecast Year [2032] USD 6.55 billion
CAGR (%) 8.88%

A concise orientation to the evolving companion animal diagnostics environment highlighting technological, clinical, and regulatory drivers reshaping care

The companion animal diagnostics landscape is undergoing a period of accelerated transformation driven by converging technological innovation, shifting clinical practices, and heightened owner expectations for more precise and timely veterinary care. Advances in assay design, imaging modalities, and molecular techniques are enabling earlier detection of disease, more personalized treatment pathways, and improved monitoring of therapeutic outcomes. As veterinary practices adopt more sophisticated in-house testing capabilities, the boundary between point-of-care screening and laboratory-grade diagnostics continues to blur, reshaping workflow models and service offerings across clinics and specialty centers.

Regulatory frameworks and professional guidelines are evolving in parallel, influencing validation standards, quality control expectations, and data governance practices for diagnostic tools and services. This dynamic regulatory context is prompting manufacturers and service providers to strengthen their evidence generation, claim substantiation, and post-market surveillance activities. Meanwhile, stakeholder expectations-from clinicians seeking rapid clinical decision support to pet owners demanding transparency and continuity of care-are incentivizing interoperable systems, standardized reporting formats, and clearer outcome metrics.

Taken together, these forces are redefining competitive differentiation. Companies that combine robust analytical performance with seamless integration into clinical workflows, strong customer support, and demonstrable clinical utility will secure the most durable positions in the market. The introduction sets the stage for a focused examination of these transformative shifts and their implications for players across the diagnostics ecosystem.

Clear articulation of the major transformative shifts altering diagnostic technologies, clinical workflows, and commercial models across veterinary practice

The landscape for companion animal diagnostics is being reshaped by several transformative shifts that are converging to redefine value propositions across the industry. First, the maturation of molecular diagnostics and next-generation sequencing has expanded the diagnostic toolkit beyond traditional morphology and serology, enabling precise pathogen identification, genetic risk profiling, and targeted oncology testing. Concurrently, point-of-care technologies and compact analyzers are decentralizing testing, allowing many practices to perform hematology, chemistry, and rapid infectious disease assays on-site, which shortens time-to-diagnosis and facilitates immediate clinical interventions.

Informatics and data integration are also rising to the fore. Cloud-based platforms, laboratory information systems, and diagnostic middleware are improving sample tracking, result interpretation, and longitudinal patient monitoring. This digital layer supports decision support algorithms and facilitates remote consultations, telemedicine follow-ups, and population-level surveillance of emerging pathogens. Additionally, growing adoption of standardized quality controls and accreditation programs is raising baseline expectations for analytical robustness across providers, which in turn influences procurement decisions and client trust.

Finally, economic and service delivery models are evolving: subscription-based service arrangements for reagents and consumables, bundled diagnostic packages, and value-based contracting for companion diagnostics are emerging as strategic approaches for suppliers. Organizations that embed clinical evidence generation, workflow integration, and responsive service models into their offerings will be better positioned to capture clinician adoption and long-term account relationships.

Practical analysis of how 2025 tariff adjustments are influencing supply chain resilience, regional sourcing strategies, and clinician procurement behavior

Tariff adjustments and trade policy changes slated for 2025 are creating a new set of operational considerations for manufacturers, distributors, and end-users in the companion animal diagnostics supply chain. Increased import duty levels on medical devices and reagents in select markets have compressed margins for vendors that rely on global sourcing, prompting a re-evaluation of distribution strategies, pricing models, and supplier relationships. Manufacturers with geographically diversified production footprints or flexible contract manufacturing arrangements are better able to mitigate near-term cost pressures and stabilize supply commitments to veterinary clinics and laboratories.

Beyond immediate cost implications, tariffs are catalyzing strategic shifts in supply chain architecture. Some suppliers are accelerating localization of component production and final assembly to reduce exposure to cross-border duties and shipping disruptions. This localization trend is influencing lead times, inventory policies, and capital investment decisions for facility expansions or partnerships. For end-users, procurement teams are revisiting total-cost-of-ownership calculations that incorporate tariff-driven price volatility, freight, and customs-related delays.

At the same time, tariff-driven market dynamics are influencing clinical adoption patterns. Where imported diagnostic platforms become less price-competitive, regional alternatives and modular in-house assay development may gain traction, especially in larger veterinary hospitals and research centers with capacity to validate new assays. Strategic collaboration between manufacturers and distributors to bundle services, offer extended warranties, and provide training can offset perceived cost increases and maintain continuity of clinical services amidst tariff-related uncertainty.

In-depth segmentation insights revealing how diagnostic test types, product classes, animal cohorts, end-user settings, and clinical applications shape strategic priorities

A granular segmentation lens clarifies where clinical need, technology fit, and commercial opportunity intersect across multiple diagnostic categories. The Type Of Diagnostic Test dimension includes hematology tests such as blood clotting assays and complete blood count panels, histopathology procedures encompassing both biopsy and cytology workflows, imaging modalities that cover ultrasound and X-ray diagnostics, molecular platforms spanning DNA sequencing and PCR-based assays, and serology approaches including agglutination assays and ELISA tests. Each test type carries distinct analytical requirements, specimen handling protocols, and training needs, which influence purchasing decisions across veterinary practices and reference laboratories.

Product Type segmentation differentiates consumables from instruments and analyzers, with consumables further characterized by reagents and test kits and instruments defined by categories such as clinical chemistry analyzers, hematology analyzers, immunodiagnostic analyzers, and molecular diagnostic instruments. This split underscores the divergent procurement rhythms between recurring reagent spend and capital expenditures for analyzers, shaping revenue models and sales strategies for suppliers.

Animal Type spans birds, cats, dogs, guinea pigs, and horses, and this diversity necessitates assay validation across species-specific reference ranges, sample matrix considerations, and clinical interpretation frameworks. End-User segmentation covers in-house testing facilities, research laboratories, and veterinary hospitals and clinics, with in-house testing facilities further segmented into animal shelters and pet owners, reflecting varying resource envelopes and technical capabilities. Application-focused segmentation includes areas such as endocrinology testing, genetic testing, infectious disease diagnostics, nutritional analysis, oncology, therapeutic drug monitoring, and toxicology testing; each application drives unique feature sets, regulatory needs, and evidence demands. Recognizing these intersecting segmentation vectors helps stakeholders prioritize product roadmaps, validation studies, and tailored commercial approaches for distinct end-user cohorts.

Strategic regional insights explaining how Americas, Europe Middle East & Africa, and Asia-Pacific markets diverge in adoption, regulation, and commercial models

Regional dynamics exert a powerful influence on technology adoption, regulatory pathways, and commercial execution strategies. In the Americas, a concentration of specialty veterinary practices and advanced reference laboratories favors rapid uptake of high-throughput molecular diagnostics and integrated practice-management workflows, supported by established distribution networks and a mature private practice ecosystem. In contrast, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with market fragmentation; established veterinary centers in Western Europe drive demand for validated, accredited solutions while emerging markets prioritize cost-effective, adaptable diagnostic options that address regional disease burdens.

In the Asia-Pacific region, rapid urbanization, growing pet ownership, and expanding veterinary education infrastructure are catalyzing demand for both point-of-care testing and advanced laboratory services. Local manufacturing and regional partnerships are increasingly important in Asia-Pacific, enabling faster market entry and responsiveness to price sensitivity. Across all regions, differences in reimbursement models, clinic consolidation trends, and professional training programs shape the pace and pattern of diagnostic uptake. Vendors must tailor their market entry strategies to account for these regional nuances, balancing standardized global product platforms with region-specific regulatory compliance, distribution frameworks, and service models to achieve sustainable adoption.

Actionable company-level insights highlighting competitive differentiation strategies, partnership pathways, and innovation priorities for sustained market relevance

Competitive dynamics within the companion animal diagnostics space are evolving as incumbent manufacturers, specialized instrument makers, reagent suppliers, and innovative molecular diagnostics firms seek differentiated value propositions. Success increasingly depends on integrated offerings that couple reliable instruments with validated consumables, streamlined workflows, and strong after-sales support. Companies that invest in clinical evidence generation, third-party validations, and cross-species reference data establish credibility with veterinary clinicians and laboratory directors, which helps sustain long-term procurement relationships.

Collaboration and strategic partnerships are emerging as effective pathways to accelerate market penetration. Alliances that combine diagnostic expertise with digital health platforms, telemedicine providers, or practice-management systems create compelling bundled solutions that address clinician workflow pain points and improve patient outcome tracking. Additionally, organizations that invest in training, remote diagnostics support, and technical service networks reduce adoption friction and enhance customer retention.

Innovation in reagent chemistry, microfluidics, and portable instrumentation is opening new competitive fronts where speed, ease of use, and assay robustness determine clinician preference. Firms that align product development with end-user realities-such as limited bench space, variable sample volumes, and the need for rapid actionable results-will command stronger market relevance. Finally, transparent post-market surveillance and responsiveness to regulatory developments reinforce trust and reduce adoption barriers for newer technologies.

Practical and prioritized recommendations for industry leaders to align product, evidence, pricing, and distribution strategies for clinical adoption and growth

Industry leaders can act decisively to convert market dynamics into competitive advantage by aligning product, evidence, and go-to-market strategies with evolving clinical needs. First, prioritize modular product architectures that allow clinics to scale capabilities from basic hematology and chemistry to more advanced molecular and serology testing without prohibitive capital outlays. This approach reduces adoption barriers and supports long-term customer relationships through upgrade pathways. In parallel, invest in robust clinical validation studies and cross-species reference data to demonstrate analytical performance and clinical utility across the most common companion animal cohorts.

Commercially, adopt flexible contracting models that combine capital equipment leasing, reagent subscription programs, and bundled service offerings to match the financial capacities of diverse end-users, from small clinics to large referral centers. Strengthen regional distribution by cultivating local manufacturing or assembly partnerships where tariff exposure or logistical constraints could undermine competitiveness. Complement product availability with targeted training programs, remote technical support, and quality assurance resources to minimize implementation friction and maximize clinician confidence.

Finally, integrate digital capabilities that enhance result interpretation, data sharing, and longitudinal patient tracking. Provide interoperable reporting formats that plug into practice-management systems and enable telemedicine workflows. By focusing on modularity, evidence generation, customer support, and digital integration, industry leaders will be positioned to capture long-term value as the companion animal diagnostics environment continues to mature.

Transparent research methodology explaining sources, expert engagement, analytical frameworks, and limitations to underpin the strategic findings

The research underpinning this analysis combined a structured review of peer-reviewed veterinary clinical literature, regulatory guidance documents, product technical specifications, and primary interviews with laboratory directors, veterinary clinicians, distributors, and product managers. Data synthesis emphasized triangulation across multiple sources to validate technology capabilities, workflow impacts, and regional adoption patterns. Qualitative inputs from subject-matter experts informed interpretation of clinical utility and operational feasibility, while secondary sources provided context on regulatory trajectories and supply chain dynamics.

Analytical methods included comparative feature mapping of diagnostic platforms, evaluation of assay validation approaches across species, and scenario analysis to assess tariff-driven supply chain responses. Emphasis was placed on reproducibility of findings and transparency of assumptions; where expert opinion informed projections about adoption likelihood or operational impacts, those judgements were corroborated with multiple practitioner interviews. Limitations include evolving regulatory actions and fast-moving technological developments that may shift dynamics after publication; accordingly, readers are encouraged to consider this research as a strategic compass that should be complemented with ongoing market monitoring and targeted validation in local practice settings.

The methodological approach ensures that the insights presented are grounded in practitioner realities, validated technical characteristics, and pragmatic commercial considerations, enabling decision-makers to apply findings to product development, procurement, and clinical integration strategies.

Concise conclusion synthesizing technological, regulatory, and commercial imperatives for strategic positioning in companion animal diagnostics

In conclusion, companion animal diagnostics stands at a strategic inflection point where technological advances, shifting care models, regulatory evolution, and economic pressures intersect to reshape value creation. The combination of molecular innovations, improved point-of-care capabilities, and integrated digital workflows is enhancing diagnostic precision while altering traditional laboratory-service relationships. Simultaneously, policy measures and tariff adjustments are prompting suppliers and distributors to reassess sourcing strategies and to strengthen regional supply resilience.

For stakeholders across the ecosystem, the path forward involves aligning product innovation with validated clinical utility, structuring commercial models that reflect end-user financial realities, and investing in service frameworks that reduce adoption friction. Regional nuance matters: targeted market approaches that consider local regulatory environments, distribution infrastructures, and clinical practice patterns will outperform one-size-fits-all strategies. Ultimately, organizations that balance technical excellence with pragmatic commercialization-backed by evidence, training, and responsive support-will lead the next phase of adoption and deliver measurable clinical and business value.

This conclusion synthesizes the principal insights and underscores the imperative for proactive strategy development to capture opportunity and mitigate operational risk in a rapidly evolving diagnostics environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising pet ownership and humanization of pets fueling daignostic demand
  • 5.2. Integration of point-of-care immunoassay devices in veterinary clinics for rapid diagnosis
  • 5.3. Rising adoption of molecular PCR testing in veterinary practices for early disease detection
  • 5.4. Advancements in telehealth-enabled diagnostic platforms for remote companion animal care
  • 5.5. Emergence of AI-driven imaging analytics to improve accuracy of small animal diagnostics
  • 5.6. Growing focus on point-of-care ultrasound adoption for comprehensive companion animal assessment
  • 5.7. Expansion of multiplex biomarker panels for early detection of chronic diseases in pets
  • 5.8. Expansion of veterinary infrastructure supporting diagnostic uptake
  • 5.9. Favorable government initiatives and pet insurance penetration boosting market expansion
  • 5.10. Rise in veterinary R&D and strategic collaborations driving innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Companion Animal Diagnostics Market, by Type Of Diagnostic Test

  • 8.1. Hematology
    • 8.1.1. Blood Clotting Test
    • 8.1.2. Complete Blood Count (CBC)
  • 8.2. Histopathology
    • 8.2.1. Biopsy
    • 8.2.2. Cytology
  • 8.3. Imaging
    • 8.3.1. Ultrasound
    • 8.3.2. X-Rays
  • 8.4. Molecular Diagnostics
    • 8.4.1. DNA Sequencing
    • 8.4.2. PCR
  • 8.5. Serology
    • 8.5.1. Agglutination Assay
    • 8.5.2. Elisa Test

9. Companion Animal Diagnostics Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Reagents
    • 9.1.2. Test kits
  • 9.2. Instruments/Analyzers
    • 9.2.1. Clinical chemistry analyzers
    • 9.2.2. Hematology analyzers
    • 9.2.3. Immunodiagnostic analyzers
    • 9.2.4. Molecular diagnostic analyzers

10. Companion Animal Diagnostics Market, by Animal Type

  • 10.1. Birds
  • 10.2. Cats
  • 10.3. Dogs
  • 10.4. Guinea pigs
  • 10.5. Horses

11. Companion Animal Diagnostics Market, by End-User

  • 11.1. In-House Testing Facilities
    • 11.1.1. Animal Shelters
    • 11.1.2. Pet Owners
  • 11.2. Research Laboratories
  • 11.3. Veterinary Hospitals & Clinics

12. Companion Animal Diagnostics Market, by Application

  • 12.1. Endocrinology Testing
  • 12.2. Genetic Testing
  • 12.3. Infectious Disease Diagnostics
  • 12.4. Nutritional Analysis
  • 12.5. Oncology
  • 12.6. Therapeutic Drug Monitoring
  • 12.7. Toxicology Testing

13. Companion Animal Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Companion Animal Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Companion Animal Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Bio-Rad Laboratories, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. Agrolabo S.p.A.
    • 16.3.4. Biogal Galed Labs
    • 16.3.5. BioMerieux S.A.
    • 16.3.6. BioNote, Inc.
    • 16.3.7. Demeditec Diagnostics GmbH
    • 16.3.8. Eurofins Technologies
    • 16.3.9. Fassisi GmbH
    • 16.3.10. FUJIFILM Holdings Corporation
    • 16.3.11. IDEXX Laboratories, Inc.
    • 16.3.12. IDvet
    • 16.3.13. Mars, Incorporated
    • 16.3.14. Neogen Corporation
    • 16.3.15. Nisseiken Co., Ltd
    • 16.3.16. Qiagen N.V.
    • 16.3.17. Randox Laboratories, Ltd.
    • 16.3.18. Shenzhen Bioeasy Biotechnology Co., Ltd.
    • 16.3.19. Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • 16.3.20. SKYER, Inc.
    • 16.3.21. Skyla Corporation
    • 16.3.22. Vimian Group AB
    • 16.3.23. Virbac S.A.
    • 16.3.24. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. COMPANION ANIMAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. COMPANION ANIMAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2